Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related ENDP
Watch Out Below, Endo International Investors, Management Is Doubling Down On Weak Assets
Benzinga's Top Downgrades
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2015 Update (Seeking Alpha)
Related FHN
Is Bank M&A Action On The Way?
Earnings Scheduled For October 16, 2015

Analysts at Cantor Fitzgerald downgraded Endo Health Solutions (NASDAQ: ENDP) from “hold” to “sell.” The target price for Endo Health Solutions is set to $30. Endo Health's shares closed at $35.96 yesterday.

Analysts at Morgan Stanley downgraded First Horizon National (NYSE: FHN) from “overweight” to “neutral.” The target price for First Horizon National is set to $11. First Horizon National's shares closed at $11.25 yesterday.

Analysts at Piper Jaffray downgraded Vera Bradley (NASDAQ: VRA) from “overweight” to “neutral.” The price target for Vera Bradley has been lowered from $32 to $24. Vera Bradley's shares closed at $22.46 yesterday.

Berenberg downgraded Oracle (NASDAQ: ORCL) from “buy” to “sell.” The target price for Oracle has been lowered from $35 to $28. Oracle's shares closed at $34.12 yesterday.

Latest Ratings for ENDP

Nov 2015Mizuho SecuritiesDowngradesBuyNeutral
Nov 2015Standpoint ResearchUpgradesHoldBuy
Nov 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for ENDP
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (ENDP + FHN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters